In a study of over 1,300 patients followed for over 10 years, patients whose breast tumors had more than 24 of CD8+ cells per high power field of the tumor had better breast cancer specific survival, 75% versus 45% (P < 0.001), than those having fewer than five [114]. This evidence concerns the gene CD8A and breast cancer.